Acquired and Native Resistance of Staphylococcus

Similar documents
Susceptibility Tests for Methicillin-Resistant (Heteroresistant) Staphylococci

Susceptibility of Staphylococcus aureus to

Staphylococcus aureus with the Disc

Resistance of Coagulase-Positive Staphylococci

NAFCILLIN AND OXACILLIN COMPARATIVE ANTISTAPHYLOCOCCAL ACTIVITY IN MICE. J. A. YURCHENCO, M. W. HOPPER, T. D. VINCE and G. H.

Detection of inducible clindamycin resistance among clinical isolates of Staphylococcus aureus in a tertiary care hospital

EDUCATIONAL COMMENTARY - Methicillin-Resistant Staphylococcus aureus: An Update

of Staphylococcus aureus

Discrepancy Between Carbenicillin and Ampicillin Activities Against Enterococci and Listeria

Resistance to cloxacillin among hospital staphylococci.

Disk Susceptibility Studies with Cefazolin and Cephalothin

Aminoglycoside-resistant enterococci

Synergism of penicillin or ampicillin combined with sissomicin or netilmicin against enterococci

Evaluation of MicroScan MIC Panels for Detection of

Effeet on Bacterial Growth

Quality Control Testing with the Disk Antibiotic Susceptibility Test of Bauer-Kirby-Sherris-Turck

GeNei TM. Antibiotic Sensitivity. Teaching Kit Manual KT Revision No.: Bangalore Genei, 2007 Bangalore Genei, 2007

Tel: Fax:

Antibiotic Susceptibility of Pseudomonas aeruginosa

Reassessment of the "Class" Concept of Disk Susceptibility Testing

Susceptibility Testing

Int.J.Curr.Microbiol.App.Sci (2018) 7(8):

56 Clinical and Laboratory Standards Institute. All rights reserved.

Comparison of Clindamycin, Erythromycin, and Methicillin in Streptococcal Infections in Monkeys

Comparison of tablets and paper discs for antibiotic sensitivity testing

against Clinical Isolates of Gram-Positive Bacteria

Evaluation of a computerized antimicrobial susceptibility system with bacteria isolated from animals

TOLYPOMYCIN, A NEW ANTIBIOTIC. V IN VITRO AND IN VIVO ANTIMICROBIAL ACTIVITY. Masahiro Kondo, Tokiko Oishi and Kanji Tsuchiya

Therapy of Staphylococcal Infections in Monkeys

Methicillin and Clindamycin resistance in biofilm producing staphylococcus aureus isolated from clinical specimens

In Vitro Activity of Netilmicin, Gentamicin, and Amikacin

January 2014 Vol. 34 No. 1

Penicillinase-Resistant Penicillins and Cephalosporins

Determination of antibiotic sensitivities by the

6.0 ANTIBACTERIAL ACTIVITY OF CAROTENOID FROM HALOMONAS SPECIES AGAINST CHOSEN HUMAN BACTERIAL PATHOGENS

SAMPLE. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals

SENSITIVE AND -RESISTANT TUBERCLE BACILLI IN LIQUID MEDIUM SENSITIVITY TESTS

Staphylococcus aureus

New Method for Antibiotic Susceptibility Testing

Correlation of Growth of Aerobic Blood Cultures in Hypertonic Broth with Antibiotic Therapy

An Approach to Linezolid and Vancomycin against Methicillin Resistant Staphylococcus Aureus

Comparative Activity of Netilmicin, Gentamicin, Amikacin, and Tobramycin Against Pseudomonas aeruginosa and Enterobacteriaceae

Improved Susceptibility Disk Assay Method Employing an

Burton's Microbiology for the Health Sciences. Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents

Q1. (a) Clostridium difficile is a bacterium that is present in the gut of up to 3% of healthy adults and 66% of healthy infants.

Penicillin, and Rifampin

Burn Infection & Laboratory Diagnosis

Scholars Research Library

Prevalence of Extended Spectrum Beta- Lactamase Producers among Various Clinical Samples in a Tertiary Care Hospital: Kurnool District, India

INDUCIBLE CLINDAMYCIN RESISTANCE AMONG CLINICAL ISOLATES OF METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS

VLLM0421c Medical Microbiology I, practical sessions. Protocol to topic J05

Principles of Antimicrobial Therapy

available. and P. aeruginosa resistant to gentamicin by standardized disk testing (1) in the Microbiology Laboratory

Klett-Summerson photoelectric colorimeter. The presence of the glucose RESISTANCE AND SYNERGISM IN STREPTOMYCIN

Antibacterial Agents & Conditions. Stijn van der Veen

DO NOT WRITE ON or THROW AWAY THIS PAPER!

Fluoroquinolones resistant Gram-positive cocci isolated from University of Calabar Teaching Hospital, Nigeria

RELIABLE AND REALISTIC APPROACH TO SENSITIVITY TESTING

There are two international organisations that set up guidelines and interpretive breakpoints for bacteriology and susceptibility

Detection of Methicillin Resistant Strains of Staphylococcus aureus Using Phenotypic and Genotypic Methods in a Tertiary Care Hospital

Methicillin-Resistant, Coagulase-Negative Staphylococci:

Brief Report THE DEVELOPMENT OF VANCOMYCIN RESISTANCE IN A PATIENT WITH METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS INFECTION

Lactose-Fermenting Bacteria Isolated from

Chemotherapy of bacterial infections. Part II. Mechanisms of Resistance. evolution of antimicrobial resistance

STAPHYLOCOCCI: KEY AST CHALLENGES

ANTIBIOTIC RESISTANCE PATTERN AGAINST VARIOUS ISOLATES OF STAPHYLOCOCCUS AUREUS FROM MILK PRODUCTS KHOYA AND BURFI

Selective toxicity. Antimicrobial Drugs. Alexander Fleming 10/17/2016

Comparison of antibiotic susceptibility results obtained with Adatab* and disc methods

Methicillin-Resistant Staphylococcus aureus

Principles and Practice of Antimicrobial Susceptibility Testing. Microbiology Technical Workshop 25 th September 2013

Ciprofloxacin, Enoxacin, and Ofloxacin against Aerobic and

Antibacterial activity of Stephania suberosa extract against methicillin-resistant Staphylococcus aureus

Randall Singer, DVM, MPVM, PhD

Methicillin resistant Staphylococcus aureus : a multicentre study

Acquisition of antibiotic resistance by

International Journal of Advances in Pharmacy and Biotechnology Vol.3, Issue-2, 2017, 1-7 Research Article Open Access.

EUCAST Expert Rules for Staphylococcus spp IF resistant to isoxazolylpenicillins

Effects of Minocycline and Other Antibiotics on Fusobacterium necrophorum Infections in Mice

Defining Resistance and Susceptibility: What S, I, and R Mean to You

Consequences of Antimicrobial Resistant Bacteria. Antimicrobial Resistance. Molecular Genetics of Antimicrobial Resistance. Topics to be Covered

MID 23. Antimicrobial Resistance. Consequences of Antimicrobial Resistant Bacteria. Molecular Genetics of Antimicrobial Resistance

Antimicrobial Resistance

Antimicrobial Resistance Acquisition of Foreign DNA

Lactose-Fermenting Bacteria Isolated from Burni Patients

Volume-7, Issue-2, April-June-2016 Coden IJABFP-CAS-USA Received: 5 th Mar 2016 Revised: 11 th April 2016 Accepted: 13 th April 2016 Research article

BIOLACTAM. Product Description. An innovative in vitro diagnostic for the rapid quantitative determination of ß-lactamase activity

Lab Exercise: Antibiotics- Evaluation using Kirby Bauer method.

Saxena Sonal*, Singh Trishla* and Dutta Renu* (Received for publication January 2012)

PDF hosted at the Radboud Repository of the Radboud University Nijmegen

Impact of Spores on the Comparative Efficacies of Five Antibiotics. Pharmacodynamic Model

Mechanism of antibiotic resistance

MICRONAUT MICRONAUT-S Detection of Resistance Mechanisms. Innovation with Integrity BMD MIC

The β- Lactam Antibiotics. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2018

ESBL Producers An Increasing Problem: An Overview Of An Underrated Threat

Test Method Modified Association of Analytical Communities Test Method Modified Germicidal Spray Products as Disinfectants

Antimicrobial Drug on Drug Resistance in the Lactose-Fermenting Enteric Flora

Prevalence of Metallo-Beta-Lactamase Producing Pseudomonas aeruginosa and its antibiogram in a tertiary care centre

Pharmacological Evaluation of Amikacin in Neonates

Challenges Emerging resistance Fewer new drugs MRSA and other resistant pathogens are major problems

Emergence of Gentamicin- and Carbenicillin-Resistant Pseudomonas aeruginosa in a Hospital Environment

Transcription:

APPLED MCROBOLOGY, JUlY 1970, p. 1-5 Copyright 1970 American Society for Microbiology Vol. 20, No.1 Printed in U.S.A. Acquired and Native Resistance of Staphylococcus aureus to Cephalexin and Other f3-lactam Antibiotics' FRTZ H. KAYSER,2 E. JACK BENNER, AND PAUL D. HOEPRCH Section rf nfecticus and mmunologic Diseases, Department of nternal Medicine, School of Medicine, University of California, Davis, California 95616 Received for publication 17 April 1970 Staphylococcus aureus cells that are initially susceptible to cephalexin can be induced to acquire intrinsic resistance to cephalexin in comparatively few steps. Concomitantly, resistance to cephalothin, oxacillin, and dicloxacillin increases. By population analysis, there is heteroresistance to cephalexin in some strains of S. aureus. Heterogeneity in colonial morphology on prolonged incubation in the presence of subinhibitory concentrations of cephalexin may constitute an expression of such heteroresistance. Some strains of Staphylococcus aureus are resistant to the penicillins and cephalosporins by mechanisms that are independent of f3-lactamase inactivation of these antibiotics; such strains are of increasing clinical importance (1). ntrinsic resistance may be acquired by a multistep increase in resistance in the course of serial transfer on culture media containing progressively greater concentrations of a penicillin (3). n addition, intrinsic resistance can be a property possessed by some strains never known to have been exposed to a penicillin or a cephalosporin. Such native intrinsic resistance is often termed "methicillin" resistance (7, 9). n earlier work (5), we reported that cephalexin, the newest of the semisynthetic cephalosporins, was active at therapeutic concentrations against only 6 of 70 strains of S. aureus with intrinsic "methicillin" resistance. Since cephalexin is less active against S. aureus than other,b-lactam antibiotics (4, 5, 12), it seemed reasonable to suppose that initially susceptible strains might acquire resistance to it in a multistep pattern. n this report, we document the step-wise development in vitro of acquired intrinsic resistance by S. aureus to cephalexin, concomitant with crossresistance to other cephalosporins and penicillins. MATERALS AND METHODS S. aureus. Seven of the eight strains of S. aureus that were studied were recent clinical isolates. The 1 Supported by grants AO-955-01 and A100384-01 from the National nstitute of Allergy and nfectious Diseases and by a grant-in-aid from Eli Lilly and Co., ndianapolis, nd. 2 Visiting Microbiologist for the year 1969 from the nstitute of Medical Microbiology, University of Zurich, Zurich, Switzerland. special properties of these strains are given in Table 1. Culture medium. Commercial formulations of Brain Heart nfusion (Bioquest Laboratories, Baltimore, Md.) as broth and as agar were used. Antimicrobial agents. Cephalexin and cephalothin were supplied by Eli Lilly & Co.; oxacillin and dicloxacillin were supplied by Bristol Laboratories. Susceptibility testing. Using a simplified modification of the Steers replicator (11), the minimal inhibitory concentrations (MC) of original strains and variants that were developed were determined by using an agar-dilution technique. Overnight cultures in broth were diluted in sterile 0.9% NaCl solution to provide inocula of 3 X 106 to 6 X 105 bacteria at each point on the agar plate. The test plates were examined for growth after 24 hr and again after 48 hr of incubation at 37 C. n some experiments, testing was done with inocula of 10 to 50 viable units per ml. The susceptibility of several single-colony isolates was examined by using the replica plate technique of Lederberg and Lederberg (10). Population analyses. Disaggregation of 24-hr broth cultures (by brief, controlled exposure to 20-kc sound) was followed by serial dilution (0.9% NaCl) and surface inoculation of agar petri plates containing 0 to 512,ug of either cephalexin, cephalothin, oxacillin, or dicloxacillin per ml. Colony counts after 48 and after 72 hr of incubation at 37 C allowed calculation of the per cent of viable units resistant to each concentration of antimicrobial agent. A single colony from the plate containing the highest concentration of cephalexin at which there was growth was picked to inoculate a tube of broth; population analysis was then repeated as described. Development of resistant strains. Development of resistance was attempted by both a disc method (8) and by serial transfer in broth. Single colonies growing within the zone of inhibition about a disc containing 30 ug of cephalexin were subcultured in broth prep-

2 KAYSER, BENNER, AND HOEPRCH APPL. MCROBOL. TABLE 1. Eight strains of S. aureus were used for study of acquisition of intrinsic resistance to cephalexin and other,8-lactam antibiotics solate Penicillin G Susceptible to Methicillin Penicillinase ~~~production lo, lo, OXACLLN <,-CEPHALEXN Pr...... + 0 Ps + + 0 Ps 80 a + _ 0 545... - + + 611 - + + 548... - + + E-208... + 49 0 a Propagation strain teriophage type 80. for staphylococcal bacaratory to a second exposure to a cephalexin disc. The procedure was repeated until there was no zone of inhibition around the disc. Tubes containing serial dilutions of cephalexin were inoculated with approximately 107 viable units per tube from an overnight broth culture of the strain of S. aureus under study. After 24 hr at 37 C, samples containing approximately 107 viable units were taken from the tube with the highest concentration of cephalexin in which growth was visible to inoculate a new set of tubes containing cephalexin. RESULTS Strains 49 and E-208 (Fig. 1) were comprised of staphylococci with differing levels of resistance to cephalexin; i.e., they were heteroresistant to cephalexin. Heteroresistance was also present with oxacillin. The basic resistance (that concentration of an antimicrobial agent that can be tolerated by 20% of the cells of the bacterial strain under study) to cephalexin was higher than it was to oxacillin; however, the maximum resistance of a minority population of each strain was similar with cephalexin and oxacillin. With the disc method, acquired intrinsic resistance was successfully induced in three strains (Table 2). Only three single-colony isolations of strain 545 were necessary to yield a variant exhibiting complete resistance by the disc test. The MC of cephalexin increased eightfold from parent to third-step variant. With strain 611, eight exposures to cephalexin were required to obtain a variant that was not inhibited by the 30-,ug disc. With the Pr strain, 11 exposures were necessary. According to replica plate MC testing, there was simultaneous increase in resistance to cephalothin, oxacillin, and dicloxacillin. Strain Ps failed to acquire intrinsic resistance by the disc-agar diffusion method. Serial transfer in broth (Table 3) yielded a -: cr) U.) CD) L' lot 104 io2 i STRAN49- STRAN E208 OXAC ~~~~~~LL N- L,- ~~CEPHALEXN 0.25 0.5 2 4 B 16 32 64 128 256 512 CONCENTRATON OF ANTBOTC (Es9 /ml) FG. 1. Populationi analysis of the susceptibility of S. aureus, strains 49 and E-208, to cephalexin and oxacillin. Although both straints were heteroresistant, the basic resistance to cephalexini exceeded that of oxacillin with both strains. TABLE 2. nductioni of intrinsic resistance in three strains of S. aureus by use of discs containing 30 jag of cephalexini in ani agar-diffusion systema Minimal inhibitory concn (pg per ml) Strain/passage Cepha- Cephalo- Oxacillin Dicloxalexin thin Oaiin cillin 545/0 8 0.5 0.5 0.25 545/3 128 4 4 2 611/0 4 0.25 0.25 0.125 611/8 256 8 8 4 Pr/0 4 0.25 0.25 0.25 Pr/11 64 1 2 1 a There was a concomitant increase in resistance to cephalothin, oxacillin, and dicloxacillin. markedly resistant variant from strain Ps after 12 transfers. Eight, seven, and five transfers were necessary with strains 545, 611, and Ps, respectively. Again, there was concomitant acquisition of intrinsic resistance to cephalothin, oxacillin, and dicloxacillin. Resistant variants were disclosed in the course of population analyses. n Fig. 2, the number of A

VOL. 20, 1970 RESSTANCE OF S. AUREUS TO ANTBOTCS 3 survivors is plotted against the concentration of cephalexin for parent strains Ps 80 and 545 and three strains developed from each parent strain. Only three to four selections were necessary with both strains to obtain highly resistant variants. To obtain more accuracy in population studies and to eliminate the possible influence of penicillinase on the results, strain Ps was used for further analyses. n Fig. 3, the numbers of surviving staphylococci are related to the concentrations of cephalexin for the parent strain Ps and two resistant variants derived from Ps. Arrows mark the concentrations at which the variants were selected. Note that the buildup of resistance accelerated with each selection step. After only three steps, a highly resistant variant was isolated. A remarkable heterogeneity of colony morphology resulted when sonically disaggregated strain Ps was incubated at 37 C for 48 hr on agar containing 0.5 to 4.0,ug of cephalexin per ml. The TABLE 3. nduction of intrinsic resistance to cephalexin in three strains of S. aureus by serial transfer in brotha Minimal inhibitory concn (pg per ml) Strain/ passage Cepba- Cephalothin Oxacillin Dicloxacillin lexincehlti Oxcli Dilxcln 545/0 8 0.5 0.5 0.25 545/4 64 2 2 1 545/9 512 32 32 32 611/0 4 0.25 0.25 0.125 611/3 64 2 2 1 611/9 512 16 16 8 PS/0 2 0.125 0.125 0.125 Ps/4 128 2 2 0.5 Ps/12 512 32 32 32 a There was a concomitant increase in resistance to cephalothin, lo,0 m 106 Ez i0j c- 0U) 104.1-1 i co -C-, LLJ co az m F- lo', 104, L STRAN PS 80 ----~~~~~~~~~~~~~~~~~~~ 8 16 32 64 128 256 512 CEPHALEXN (p9g/ml) FG. 2. Number of surviving S. aureus is presented as a function of the concentration of cephalexin in the culture medium for parent strains Ps 80 and 545 and for three variants from each strain picked from plates containing cephalexin, as designated by the arrows. 0 L colonies differed in size and there was a high degree of irregularity (Fig. 4, 5). The large colonies were often composed of a flat, translucent zone and a denser, yellow part (Fig. 4). Protrulol!- cr- z 0D 2 3 4 5 2 4 8 z 16 z2 24 z8 3z 36 40 CEPHALEXN ( #g / ml) 20 60 100 140 180 200 FG. 3. Number of resistant S. aureus is related to the concentration of cephalexin for parent strain Ps and two variants derived at the concentrations marked by the arrows.

4 KAYSER, BENNER, AND HOEPRCH APPL. MCROBOL. TABLE 4. Marked heterogeneity in colonial morphology after 48 hr of incubation of strain Ps in the presence of subinhibitory concenitrations of cephalexina Colonies Minimal inhibitory concn (,g per ml) ~~~~~ard No. No. Stand- Source exam- Mean deviained tion FG. 4. Heterogeneity in colony morphology of S. aureus strain Ps after 48 hr of incubationz in the presence of 1.2,ug of cephalexin per ml. X 100. FG. 5. Protuberant growth distorting the circumference of a large colony of S. aureus strain Ps after 48 hr of incubation in the presence of 1.5,g of cephalexin per ml. X 100. sions frequently marred the circumference of the large colonies (Fig. 5). The small colonies often contained daughter colonies that differed in density and color. Similar daughter colonies were also observed within the large colonies. These No cephalexin... 55 2 4 0 0 Large colonies, 2.5 to 4 Ag of cephalexin per ml... 20 5.47 i 0. 11 0.50 Small colonies, 2.5 to 4 Ag of cephalexin per ml... 20 3.96 i 0.20 0.92 Cephalexin (0.5 to 2 jg per ml) Parent colony... 25 2.17 i 0.07 0.38 Protuberance.. 20 6.68 i0.68 3.06 Cephalexin (0.5 to 2 Mg per ml) Parent colony... 15 2 ± 0 0 ntracolony daughter... 15 5.46 i 0.45 1.76 Variation in susceptibility of cephalexin accompanied the alteration in colonial morphology. peculiarities of colonial morphology were not evident after 12 hr of incubation. Differences in susceptibility to cephalexin were found when various portions of the irregular colonies were compared with colonies grown on agar free from cephalexin (Table 4). For testing of susceptibility, portions of colonies selected according to morphology were inoculated into broth, incubated overnight, and then diluted to provide inocula of 10 to 50 viable units. Fiftyfive colonies from antibiotic-free agar exhibited uniform susceptibility to 2.0 jig of cephalexin per ml. n addition, with the replica plate method (10), in which the inoculum is higher, 771 of 812 colonies yielded cells that were inhibited by 2.0 Mg of cephalexin per ml; 41 were inhibited by 2.5 Mg per ml. Regular, large colonies were more resistant than small colonies. ntracolony daughter colonies and protuberances were more resistant to cephalexin than the remainder of the colony. Similar, though less striking, results were obtained with first and second step variants. DSCUSSON n strains of S. aureus with native intrinsic resistance, at the same time the basic resistance to oxacillin was low, the basic resistance to cephalexin was high. For example, the basic resistance

VOL. 20, 1970 RESSTANCE OF S. AUREUS TO ANTBOTCS of strain 49 was 16 times higher for cephalexin than for oxacillin. These data not only substantiate the earlier observations of the comparatively low potency of cephalexin (4, 5, 12), but also define a characteristic profile of activity in relating degree of resistance to fraction of staphylococcal population. Acquisition of intrinsic resistance to cephalexin was readily achieved. The buildup of resistance followed a multistep pattern. However, unlike other f-lactam antibiotics, the steps were huge since as few as three yielded variants resistant to high concentrations of cephalexin. t is possible that rapid, multistep acquisition of intrinsic resistance can be achieved during treatment of staphylococcal infections with cephalexin. However, should such variants arise, it may be that they would also be reduced in virulence after the fashion of variants with acquired intrinsic resistance to oxacillin (7). Unquestionably, increased resistance to cephalexin is associated with increased resistance to cephalothin, oxacillin, and dicloxacillin. Yet, it cannot be said that complete cross-resistance exists; the term decreased susceptibility is preferable. t is possible that a stepwise increase in resistance results from independent mutations at genetic loci that direct the synthesis of target sites of the f3-lactam antibiotics, affecting, with each step, a reduction in the affinity of antibiotic: target site. The isolation of variants with different degrees of resistance could be explained in this way, since mutations at different loci might result in different degrees of resistance. Only a genetic analysis can confirm or refute this hypothesis. Since cephalexin is a f3-lactam antibiotic of low potency, it may be of particular utility to the study of the multistep pattern of development of resistance. Colony size correlates with the observed differences in resistance. Thus, the more resistant cells are inhibited less and form large colonies; the less resistant cells are restrained in growth and form small colonies. Heterogeneity in colonial morphology may reflect mutations occurring during growth, since young colonies were morphologically homogeneous. f, as colonies age, mutants with different degrees of resistance arise, their multiplication at the edge of a colony would result in a protuberance or an intracolony daughter if centrally located. LTERATURE CTED 1. Benner, E. J., and F. H. Kayser. 1968. Growing clinical significance of methicillin-resistant Staphylococcus aureus. Lancet 2:741-746. 2. Bryson, V., and M. Demerec. 1950. Patterns of resistance to antimicrobial agents. Ann. N.Y. Acad. Sci. 53:283-288. 3. Demerec, M. 1945. Production of Staphylococcus strains resistant to various concentrations of penicillin. Proc. Nat. Acad. Sci. U.S.A. 31:16-24. 4. Griffith, R. S., and H. R. Black. 1968. Cephalexini. a new antibiotic. Clin. Med. 75:14-20. 5. Hoeprich, P. D., E. J. Benner, and F. H. Kayser. 1970. Susceptibility of "methicillin"-resistant Staphylococcits auceius to 12 antimicrobial agents. Antimicrob. Ag. Chernother.- 1969, p. 104-1 10. 6. Kayser, F. H. 1966. Ueber die Oxacillinresistenz pathogener Staphylokokken. V. Vorkommen und Bedeutung von Staphylokokkenstammen mit '-inhbirenter Penicillinresistenz." Z. Med. Mikrobiol. mmunol. 153:48-51. 7. Kayser, F. H., and U. Wiemer. 1965. Ueber die Oxacillinresistenz pathogener Staphylokokken.. Die Natur der Resistenz gegen Oxacillin bei S. pyogenes aureus. Z. Hyg. nfektionskr. 150:308-314. 8. Kind, A. C., D. G. Kestle, H. C. Standiford, P. Freeman, and W. M. M. Kirty. 1969. Development of staphylecocci cross-resistant to cephalexin and methicillin. Antimicrob. Ag. Chemother.-1968, p. 405-409. 9. Knox, R., and J. T. Smith. 1963. Stability of methicillin and cloxacillin to staphylococcal penicillinase. Brit. Med. J. 2:205. 10. Lederberg, J., and E. M. Lederberg. 1952. Replica plating and indirect selection of bacterial mutants. J. Bacteriol. 63:399-406. 11. Steers, R. 1959. An inoculator replicating apparatus for routine testing of bacterial susceptibility to antibiotics. Antibiot. Chemother. 9:307-309. 12. Wick, W. E. 1965. Cephalexin, a new orally absorbed cephalosporin antibiotic. Appl. Microbiol. 15:765-769. 5